Hims & Hers Health
HIMS
504 hedge funds and large institutions have $5.38B invested in Hims & Hers Health in 2026 Q2 according to their latest regulatory filings, with 143 funds opening new positions, 176 increasing their positions, 131 reducing their positions, and 66 closing their positions.
117% more first-time investments, than exits
New positions opened: 143 | Existing positions closed: 66
80% more funds holding in top 10
Funds holding in top 10: 5 → 9 (+4)
74% more capital invested
Capital invested by funds: $3.1B → $5.38B (+$2.28B)
41% more call options, than puts
Call options by funds: $1.54B | Put options by funds: $1.1B
34% more repeat investments, than reductions
Existing positions increased: 176 | Existing positions reduced: 131
16% more funds holding
Funds holding: 435 → 504 (+69)
1.73% more ownership
Funds ownership: 68.04% → 69.76% (+1.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$149M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$114M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$93.8M |
| 4 |
Goldman Sachs
New York
|
+$73M |
| 5 |
BlackRock
New York
|
+$63.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DE
Defiance ETFs
New York
|
-$154M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$54.9M |
| 3 |
Morgan Stanley
New York
|
-$46.6M |
| 4 |
Renaissance Technologies
New York
|
-$44M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$43.1M |
HIMS Hedge Fund Activity: Q2 2026 in Review
504 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Hims & Hers Health (HIMS) for Q2 2026, worth a combined $5.38B — up 74% from $3.1B a quarter earlier.
Buyers outnumbered sellers: 143 funds opened new HIMS positions and 66 closed out — a net gain of 77 holders — while 176 added to existing stakes and 131 trimmed.
The largest buyer was Divisadero Street Capital Management, adding an estimated $149M. The largest seller was Defiance ETFs, exiting entirely with an estimated $154M sold.
- 504 institutional investors held Hims & Hers Health (HIMS) as of Q2 2026, up from 435 in Q1 2026.
- Funds reported $5.38B of Hims & Hers Health stock for Q2 2026, up 74% quarter-over-quarter.
- 143 funds opened new Hims & Hers Health positions in Q2 2026 and 66 closed out, a net change of +77 holders.
- The largest Hims & Hers Health buyer in Q2 2026 was Divisadero Street Capital Management, an estimated $149M added.
- The largest Hims & Hers Health seller in Q2 2026 was Defiance ETFs, an estimated $154M sold.
Based on aggregated 13F filings for Q2 2026.